戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 press both a nucleoside kinase as well as an equilibrative nucleoside transporter.
2 recently cloned dipyridamole-sensitive human equilibrative nucleoside transporter.
3 ine, but not other deoxynucleosides, through equilibrative nucleoside transporters.
4 permease is related in sequence to mammalian equilibrative nucleoside transporters.
5                                  Erythrocyte equilibrative nucleoside transporter 1 (eENT1) levels ar
6 s following uptake into activated T cells by equilibrative nucleoside transporter 1 (ENT1) and inhibi
7                      They import purines via equilibrative nucleoside transporter 1 (ENT1) homologs.
8 s a consequence of ticagrelor inhibiting the equilibrative nucleoside transporter 1 (ENT1) on platele
9                            Overexpression of equilibrative nucleoside transporter 1 (ENT1) or concent
10 ecently, a variant of adenosine transporter, equilibrative nucleoside transporter 1 (ENT1), was assoc
11                     However, the role of the equilibrative nucleoside transporter 1 (ENT1), which is
12 s RBV uptake by preventing the expression of equilibrative nucleoside transporter 1 (ENT1).
13                         Mechanistically, the equilibrative nucleoside transporter 1 (ENT1, SLC29A1) r
14 iation in the last extracellular loop of the equilibrative nucleoside transporter 1 (ENT1; also calle
15    Inhibitor and substrate interactions with equilibrative nucleoside transporter 1 (ENT1; SLC29A1) a
16                      We identified the human equilibrative nucleoside transporter 1 (hENT1) as the mo
17                                    The human equilibrative nucleoside transporter 1 (hENT1) is an imp
18      We have previously shown that the human equilibrative nucleoside transporter 1 (hENT1) is expres
19 e whether the nucleoside transporters, human equilibrative nucleoside transporter 1 (hENT1) or human
20 nomolar concentrations specifically to human equilibrative nucleoside transporter 1 (hENT1) produced
21 H-Thymidine transport was dominated by human equilibrative nucleoside transporter 1 (hENT1) under bot
22                                    The human equilibrative nucleoside transporter 1 (hENT1), a member
23 toxicity include the activities of the human equilibrative nucleoside transporter 1 (hENT1), deoxycyt
24                      The expression of human equilibrative nucleoside transporter 1 (hENT1), thymidin
25  cells expressing thymidine kinase and human equilibrative nucleoside transporter 1 (hENT1).
26                    The Plasmodium falciparum Equilibrative Nucleoside Transporter 1 (PfENT1) is a mem
27 . falciparum, the most virulent species, the equilibrative nucleoside transporter 1 (PfENT1) represen
28 thase (TYMS), thymidine kinase 1 (TK-1), and equilibrative nucleoside transporter 1 (SLC29A1) in HCC
29 specific and FKBP-dependent inhibitor of the equilibrative nucleoside transporter 1 and is efficaciou
30           CBD inhibited adenosine uptake via equilibrative nucleoside transporter 1 and synergistical
31 inding studies confirm that CBD binds to the equilibrative nucleoside transporter 1 with a Ki < 250 n
32 enzymes (connexin43, connexin37, pannexin-1, equilibrative nucleoside transporter 1, CD39, CD73, ecto
33 g an astrocytic adenosine transporter, ENT1 (equilibrative nucleoside transporter 1; Slc29a1), show n
34 ntine) is a clinically used vasodilator with equilibrative nucleoside transporters 1 and 2 (ENT1 and
35       We stably transfected the cloned human equilibrative nucleoside transporters 1 and 2 (hENT1 and
36 ed remdesivir and EIDD-1931 as substrates of equilibrative nucleoside transporters 1 and 2.
37 brative nucleoside transporter family member equilibrative nucleoside transporter-1 (ENT1) in the reg
38 investigated the effect on tumor immunity of equilibrative nucleoside transporter-1 (ENT1), the major
39 lism by potently and directly inhibiting the equilibrative nucleoside transporter-1 (ENT1).
40                      Low expression of human equilibrative nucleoside transporter-1 (hENT1) may resul
41 raC-8C cells that are deficient in the human equilibrative nucleoside transporter-1, the IC(50) of Ge
42 eling and experimental studies revealed that equilibrative nucleoside transporter 2 (ENT2), but not E
43   (3)H-FMAU transport was dominated by human equilibrative nucleoside transporter 2.
44         Here, we found that mice lacking the equilibrative nucleoside transporter 3 (ENT3) developed
45                           Mutations in human equilibrative nucleoside transporter 3 (ENT3) encoded by
46                     Mutations exclusively in equilibrative nucleoside transporter 3 (ENT3), the only
47 mutations in SLC29A3, encoding the lysosomal equilibrative nucleoside transporter 3 (ENT3).
48 ntracellular uptake depends predominantly on equilibrative nucleoside transporters after conversion o
49                                              Equilibrative nucleoside transporters are a unique famil
50 studies demonstrate that the NBMPR-sensitive equilibrative nucleoside transporters are novel and unex
51 sine A2B receptor agonists and inhibition of equilibrative nucleoside transporters by dipyridamole ma
52 mercaptopurine riboside (NBMPR)-insensitive, equilibrative nucleoside transporter ei by functional co
53                                              Equilibrative nucleoside transporters encompass two cons
54  the first to predict drug interactions with equilibrative nucleoside transporter (ENT) 1 and ENT2 us
55 rter (CNT) blocker phloridzin but not by the equilibrative nucleoside transporter (ENT) blocker dipyr
56 while requiring intracellular uptake via the equilibrative nucleoside transporter (ENT) ENT1 or the c
57 s a newly cloned transporter assigned to the equilibrative nucleoside transporter (ENT) family (SLC29
58                          Transporters of the equilibrative nucleoside transporter (ENT) family promot
59 de Transporter 1 (PfENT1) is a member of the equilibrative nucleoside transporter (ENT) gene family.
60 cause lung injury via adenosine receptors or equilibrative nucleoside transporter (ENT)-dependent int
61                   They import purines via an equilibrative nucleoside transporter (ENT).
62 o the recently cloned human NBMPR-sensitive, equilibrative nucleoside transporter ENT1 and thus was d
63        Here, we show that the absence of the equilibrative nucleoside transporter (ENT1) in human red
64 anol-sensitive adenosine transporter, type 1 equilibrative nucleoside transporter (ENT1), drink more
65 the nitrobenzylthioinosine (NBMPR)-sensitive equilibrative nucleoside transporter (ENT1), incubation
66 adenosine signaling by inhibiting the type 1 equilibrative nucleoside transporter (ENT1), whereas chr
67 ng to a novel isoform of the NBMPR-sensitive equilibrative nucleoside transporter (ENT1).
68 ble to penetrate into cells deficient in the equilibrative nucleoside transporter ENT2, and reconstit
69                                              Equilibrative nucleoside transporters (ENTs) 1 and 2 fac
70 entrative nucleoside transporters (CNTs) and equilibrative nucleoside transporters (ENTs) are importa
71                                              Equilibrative nucleoside transporters (ENTs) are polytop
72                                              Equilibrative nucleoside transporters (ENTs) are present
73              Consistent with the notion that equilibrative nucleoside transporters (ENTs) terminate a
74                                              Equilibrative nucleoside transporters (ENTs) translocate
75 ards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothe
76 ignaling is terminated by its uptake through equilibrative nucleoside transporters (ENTs).
77 e occurred by translocation of adenosine via equilibrative nucleoside transporters (ENTs).
78 de membrane transport: the concentrative and equilibrative nucleoside transporter families.
79 identifies three transport mechanisms of the equilibrative nucleoside transporter family by which nuc
80  the first demonstration that members of the equilibrative nucleoside transporter family can be elect
81                             Permeases of the equilibrative nucleoside transporter family mediate the
82         Previous studies have implicated the equilibrative nucleoside transporter family member equil
83                   Permeases belonging to the equilibrative nucleoside transporter family promote upta
84          The first mammalian examples of the equilibrative nucleoside transporter family to be charac
85  being imported into cells by members of the equilibrative nucleoside transporter family, NR is predo
86                     LdNT2 is a member of the equilibrative nucleoside transporter family, which posse
87 ituted gate operates in other members of the equilibrative nucleoside transporter family.
88        PfNT2 is, like PfNT1, a member of the equilibrative nucleoside transporter family.
89  but exhibits low homology to members of the equilibrative nucleoside transporter family.
90 s that is homologous to other members of the equilibrative nucleoside transporter family.
91 substantial homology to other members of the equilibrative nucleoside transporter family.
92 topology similar to members of the mammalian equilibrative nucleoside transporter family.
93 ishmania donovani express two members of the equilibrative nucleoside transporter family; LdNT1 encod
94 1 receptors but required adenosine uptake by equilibrative nucleoside transporters followed by its (i
95  the hypothesis that human concentrative and equilibrative nucleoside transporters (hCNT1 and hENT1)
96 or DNA and correlating its uptake with human equilibrative nucleoside transporter (hENT1) levels, str
97                                    The human equilibrative nucleoside transporter (hENT1) protein tra
98 s thymidine kinase gene (hsv-tk) and a human equilibrative nucleoside transporter (hENT1).
99                                    The human equilibrative nucleoside transporter, hENT1, which is se
100 exposure of SKOV-3 cells to dipyridamole, an equilibrative nucleoside transporter inhibitor; APCP, a
101 onstrate that Fun26, a homolog of human ENT (equilibrative nucleoside transporter), localizes to the
102 enosine kinase, adenosine deaminase, and the equilibrative nucleoside transporter: mature receptors w
103                                              Equilibrative nucleoside transporters of the SLC29 famil
104                                              Equilibrative nucleoside transporters play essential rol
105 hich inhibits transport of adenosine through equilibrative nucleoside transporter, raised the measure
106                                      The rat equilibrative nucleoside transporter (rENT1) was reveale
107                                          The equilibrative nucleoside transporter subtype 1 (ENT1) pl
108                                   ENT1 is an equilibrative nucleoside transporter that enables trans-
109 on of the adenosine transporter ENT1 (type 1 equilibrative nucleoside transporter), which provides pr

 
Page Top